Development and validation of a ‘tablet pole’ for the administration of praziquantel in sub-Saharan Africa

Abstract
A pole estimating, for each individual, the number of praziquantel tablets needed for treatment according to height was tested in 20 data sets (n = 25 688). In more than 98% of the cases the indicated dose was within the range that has proven efficacious and safe (30 and 60 mg/kg).